Paclitaxel-coated balloon angioplasty versus drug-eluting stenting for the treatment of infrapopliteal long-segment arterial occlusive disease: The IDEAS randomized controlled trial

JACC: Cardiovascular Interventions

Volumn 7, Issue 9, 2014, Pages 1048-1056

  Siablis, Dimitris ^a   Kitrou, Panagiotis M ^a   Spiliopoulos, Stavros ^a   Katsanos, Konstantinos ^b   Karnabatidis, Dimitris ^a  

^a UNIVERSITY HOSPITAL OF PATRAS   (Greece)

^b GUY'S AND ST THOMAS' NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

drug eluting stents; infrapopliteal lesions; neointimal hyperplasia; paclitaxel coated balloons; restenosis

Indexed keywords

HEPARIN; BIOMATERIAL; CARDIOVASCULAR AGENT; PACLITAXEL;

AGED; AMPUTATION; ANGIOGRAPHY; ARTICLE; BALLOON; BLOOD VESSEL WALL; CLINICAL ARTICLE; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; DEVICE COMPARISON; DIGITAL SUBTRACTION ANGIOGRAPHY; DRUG ELUTING STENT; EVEROLIMUS ELUTING STENT; FEMALE; FOLLOW UP; HUMAN; LONG INFRAPOPLITEAL LESION; MALE; MORTALITY; PACLITAXEL COATED BALLOON; PERIPHERAL OCCLUSIVE ARTERY DISEASE; QUANTITATIVE ANALYSIS; RANDOMIZED CONTROLLED TRIAL; RESTENOSIS; REVASCULARIZATION; SIROLIMUS ELUTING STENT; TIBIAL ARTERY; WOUND HEALING; ZOTAROLIMUS ELUTING STENT; ADVERSE EFFECTS; CENTRAL VENOUS CATHETER; COMPARATIVE STUDY; DEVICES; GREECE; LIMB SALVAGE; MIDDLE AGED; PATHOPHYSIOLOGY; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PERIPHERAL ARTERIAL DISEASE; POPLITEAL ARTERY; PROSPECTIVE STUDY; PROSTHESIS; RADIOGRAPHY; RECURRENT DISEASE; STENOSIS, OCCLUSION AND OBSTRUCTION; TIME; TREATMENT OUTCOME; VASCULAR PATENCY; VASCULAR REMODELING; VERY ELDERLY;

AGED; AGED, 80 AND OVER; AMPUTATION; ANGIOGRAPHY, DIGITAL SUBTRACTION; ANGIOPLASTY, BALLOON; CARDIOVASCULAR AGENTS; COATED MATERIALS, BIOCOMPATIBLE; CONSTRICTION, PATHOLOGIC; DRUG-ELUTING STENTS; FEMALE; GREECE; HUMANS; LIMB SALVAGE; MALE; MIDDLE AGED; PACLITAXEL; PERIPHERAL ARTERIAL DISEASE; POPLITEAL ARTERY; PROSPECTIVE STUDIES; PROSTHESIS DESIGN; RECURRENCE; TIME FACTORS; TREATMENT OUTCOME; VASCULAR ACCESS DEVICES; VASCULAR PATENCY; VASCULAR REMODELING;

EID: 84908141955     PISSN: 19368798     EISSN: 18767605     Source Type: Journal    
DOI: 10.1016/j.jcin.2014.04.015     Document Type: Article

References (24)

1. T.W. Rooke, A.T. Hirsch, S. Misra for the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines, Society for Cardiovascular Angiography and Interventions, Society of Interventional Radiology, Society for Vascular Medicine, Society for Vascular Surgery 2011 ACCF/AHA focused update of the guideline for the management of patients with peripheral artery disease (updating the 2005 guideline): a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines J Am Coll Cardiol 58 2011 2020 2045
2. F. Verzini, P. De Rango, G. Isernia, G. Simonte, L. Farchioni, and P. Cao Results of the "endovascular treatment first" policy for infrapopliteal disease J Cardiovasc Surg (Torino) 53 Suppl 1 2012 179 188
3. M. Bosiers, J.P. Hart, K. Deloose, J. Verbist, and P. Peeters Endovascular therapy as the primary approach for limb salvage in patients with critical limb ischemia: experience with 443 infrapopliteal procedures Vascular 14 2006 63 69
4. J.H. Peregrin, B. Koznar, and J. Kovác PTA of infrapopliteal arteries: long-term clinical follow-up and analysis of factors influencing clinical outcome Cardiovasc Intervent Radiol 33 2010 720 725
5. H. Odink, A. van den Berg, and B. Winkens Technical and clinical long-term results of infrapopliteal percutaneous transluminal angioplasty for critical limb ischemia J Vasc Interv Radiol 23 2012 461 467 467.e1
6. D. Siablis, P. Kraniotis, D. Karnabatidis, G.C. Kagadis, K. Katsanos, and J. Tsolakis Sirolimus-eluting versus bare stents for bailout after suboptimal infrapopliteal angioplasty for critical limb ischemia: 6-month angiographic results from a nonrandomized prospective single-center study J Endovasc Ther 12 2005 685 695
7. D. Siablis, D. Karnabatidis, and K. Katsanos Sirolimus-eluting versus bare stents after suboptimal infrapopliteal angioplasty for critical limb ischemia: enduring 1-year angiographic and clinical benefit J Endovasc Ther 14 2007 241 250
8. D. Karnabatidis, K. Katsanos, and D. Siablis Infrapopliteal stents: overview and unresolved issues J Endovasc Ther 16 Suppl 1 2009 I153 I162
9. M. Bosiers, K. Deloose, J. Verbist, and P. Peeters Percutaneous transluminal angioplasty for treatment of "below-the-knee" critical limb ischemia: early outcomes following the use of sirolimus-eluting stents J Cardiovasc Surg (Torino) 47 2006 171 176
10. D. Scheinert, K. Katsanos, T. Zeller for the ACHILLES Investigators A prospective randomized multicenter comparison of balloon angioplasty and infrapopliteal stenting with the sirolimus-eluting stent in patients with ischemic peripheral arterial disease: 1-year results from the ACHILLES trial J Am Coll Cardiol 60 2012 2290 2295
11. A. Rastan, G. Tepe, and H. Krankenberg Sirolimus-eluting stents vs. bare-metal stents for treatment of focal lesions in infrapopliteal arteries: a double-blind, multi-centre, randomized clinical trial Eur Heart J 32 2011 2274 2281
12. M. Bosiers, D. Scheinert, and P. Peeters Randomized comparison of everolimus-eluting versus bare-metal stents in patients with critical limb ischemia and infrapopliteal arterial occlusive disease J Vasc Surg 55 2012 390 398
13. K. Katsanos, S. Spiliopoulos, A. Diamantopoulos, D. Karnabatidis, T. Sabharwal, and D. Siablis Systematic review of infrapopliteal drug-eluting stents: a meta-analysis of randomized controlled trials Cardiovasc Intervent Radiol 36 2013 645 658
14. K. Katsanos, D. Karnabatidis, P. Kitrou, S. Spiliopoulos, N. Christeas, and D. Siablis Paclitaxel-coated balloon angioplasty vs. plain balloon dilation for the treatment of failing dialysis access: 6-month interim results from a prospective randomized controlled trial J Endovasc Ther 19 2012 263 272
15. S. Cassese, R.A. Byrne, and I. Ott Paclitaxel-coated versus uncoated balloon angioplasty reduces target lesion revascularization in patients with femoropopliteal arterial disease: a meta-analysis of randomized trials Circ Cardiovasc Interv 5 2012 582 589
16. A. Schmidt, M. Piorkowski, and M. Werner First experience with drug-eluting balloons in infrapopliteal arteries: restenosis rate and clinical outcome J Am Coll Cardiol 58 2011 1105 1109
17. F. Fanelli, A. Cannavale, and E. Boatta Lower limb multilevel treatment with drug-eluting balloons: 6-month results from the DEBELLUM randomized trial J Endovasc Ther 19 2012 571 580
18. F. Liistro, I. Porto, and P. Angioli Drug-eluting balloon in peripheral intervention for below the knee angioplasty evaluation (DEBATE-BTK): a randomized trial in diabetic patients with critical limb ischemia Circulation 128 2013 615 621
19. L. Graziani, A. Silvestro, and V. Bertone Vascular involvement in diabetic subjects with ischemic foot ulcer: a new morphologic categorization of disease severity Eur J Vasc Endovasc Surg 33 2007 453 460
20. A. Schmidt, M. Ulrich, and B. Winkler Angiographic patency and clinical outcome after balloon-angioplasty for extensive infrapopliteal arterial disease Catheter Cardiovasc Interv 76 2010 1047 1054
21. D. Karnabatidis, S. Spiliopoulos, and A. Diamantopoulos Primary everolimus-eluting stenting versus balloon angioplasty with bailout bare metal stenting of long infrapopliteal lesions for treatment of critical limb ischemia J Endovasc Ther 18 2011 1 12
22. K. Katsanos, D. Karnabatidis, A. Diamantopoulos, S. Spiliopoulos, and D. Siablis Cost-effectiveness analysis of infrapopliteal drug-eluting stents Cardiovasc Intervent Radiol 36 2013 90 97
23. F. Alfonso, M.J. Perez-Vizcayno, and M. Ruiz Coronary aneurysms after drug-eluting stent implantation: clinical, angiographic, and intravascular ultrasound findings J Am Coll Cardiol 53 2009 2053 2060
24. M. Werk, T. Albrecht, and D.R. Meyer Paclitaxel-coated balloons reduce restenosis after femoro-popliteal angioplasty: evidence from the randomized PACIFIER trial Circulation Cardiovascular interventions 5 2012 831 840